Ceftibuten is a third-generation cephalosporin antibiotic. It is an orally-administered agent with 2 dosage forms capsule or oral suspension. It is marketed by Pernix Therapeutics under the trade name Cedax.It is active against Haemophilus influenzae Moraxella catarrhalis Escherichia coli (K. pneumoniae K. oxytoca) Proteus vulgaris P. mirabils P. providence Salmonella sp. Shigella sp. Enterobacter sp. and Streptococcus sp.
This page contains content from the copyrighted Wikipedia article "Ceftibuten"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.